托法西提尼酸盐基于协调的双响应/清洁器纳米平台,旨在调节结肠炎症微环境以缓解大肠炎
Jiafeng Zou1, Kun Jiang1, You Chen1
1Shanghai Frontier Science Center of Optogenetic Techniques for Cell Metabolism, School of Pharmacy, East China University of Science and Technology, Shanghai, 200237, China.
Advanced healthcare materials
|August 24, 2024
概括
一个新的纳米粒子通过在结肠中清理反应性氧物种和硫化来有效治疗性结肠炎. 这种双重作用的纳米药物针对炎症,为患者提供了有前途且安全的口服治疗选择.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术 纳米技术
- 胃肠病学 胃肠病学
背景情况:
- 性结肠炎涉及免疫失调和肠道炎症.
- 开发安全的口服纳米药物对于结肠炎治疗至关重要.
- 通过清除活性氧物种 (ROS) 和硫化 (H2S) 来向结肠炎症微环境是关键的治疗策略.
研究的目的:
- 为了合成和表征一种新的纳米粒子,用于ROS和H2S的双重清理.
- 为了提高纳米颗粒的稳定性和针对炎症结肠病变的准能力.
- 通过调节炎症微环境来评估纳米平台在治疗大肠炎中的有效性.
主要方法:
- 托法西提尼布酸盐和铜基于协调的纳米粒子 (T-C) 的合成.
- 封装T-C用氨酸修饰的奇托和培涂层 (T-C@HP) 增强稳定性和准.
- 使用生物传感器 (HyPer7, iNap1/c) 和化学探针来调查ROS/H2S清理和NADPH水平.
- 在大肠炎模型中评估纳米平台对亡,巨细胞两极分化,紧密结节,粘液层和肠道菌群的影响.
主要成果:
- 该T-C@HP纳米平台展示了双重pH/pectinase响应特征,用于针对性地向炎症结肠病变传递.
- T-C@HP有效地清除了ROS和H2S,增加了NADPH水平,并抑制了酸化的Janus激酶1.
- 纳米平台调节了结肠炎症微环境的关键方面,从而缓解了结肠炎.
- 观察到令人满意的抗炎和生物安全性.
结论:
- 开发的T-C@HP纳米平台为性结肠炎提供了一个有前途,有效和安全的口服治疗方法.
- 通过T-C@HP对ROS和H2S进行双重清理,在调节结肠炎症微环境方面起着至关重要的作用.
- 这种纳米医学方法有可能改善结肠炎患者的治疗结果.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
120
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
120
Drugs for Treatment of Ulcerative Colitis in IBD
130
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
130
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
145
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
145
Inflammatory Bowel Disease IV: Pharmacological Management
123
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
123
Inflammatory Response
1.9K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
1.9K
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
98
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
98


